A complete application in a minute — tailored resume and cover letter, ready to send.
Damora Therapeutics is seeking a Director of Clinical Data Management to own end‑to‑end data handling for first‑in‑human oncology programs. You will collaborate with Clinical Operations, Translational Medicine, Safety, and Biostatistics to enable rapid, safety‑driven decision making in a lean biotech setting.
You will manage data management activities from protocol development through database lock, oversee CRO/vendors, ensure GCP/GCDMP/CDISC compliance, and drive inspection readiness for
Damora Therapeutics is an innovative biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. We are advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is significant medical need for new disease-modifying treatments. With multiple programs with best-in-class potential on track to enter clinical development in 2026, our goal is to rapidly bring forward optimized treatments with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes.
This is a unique opportunity to join a science-driven company at a formative stage, where early clinical data will directly shape development strategy and drive long-term value. The right candidate will join a team with significant early- and late-stage development experience, with the goal of quickly moving through dose escalation/expansion into pivotal trials.
The Director of Clinical Data Management is a senior individual contributor responsible for the hands‑on execution and delivery of high-quality, inspection-ready clinical trial data for first‑in‑human (FIH) oncology programs. This role provides end‑to‑end ownership of data management activities from protocol development through database lock, interim analyses, and regulatory interactions.
Operating in a lean biotech environment, this position requires deep early‑phase oncology expertise, independent judgment, and close collaboration with Clinical Operations, Translational Medicine, Safety, and Biostatistics to support rapid, safety‑driven decision‑making.
At Damora Therapeutics, we offer competitive compensation and thoughtfully designed total rewards aligned with industry benchmarks. We believe in rewarding impact and building meaningful ownership for our team.
We are building our team intentionally and do not accept unsolicited resumes from recruiting or staffing agencies. Agencies should not submit candidates unless directly engaged by Damora’s HR team and operating under a signed agreement. Any resume submitted without prior authorization and a signed agreement will be considered property of Damora Therapeutics, and no referral or placement fees will be paid.